Position in BNTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$20,338,588
+$14,959,788 QoQ
Shares Held
228,832
+305.0% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
1.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 58.26632638791778.ToString("F0")%
Shared 0.ToString("F0")%
None 41.73367361208223.ToString("F0")%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Derivatives in BNTX
reported options exposure · as of Mar 31, 2024CallValue
$4,151,250
CallShares
45,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Quinn Opportunity Partners LLC holds $55,803,564 across 25 Biotechnology names. BNTX ranks #1 (36.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BNTX |
BioNTech SE
This page
|
228,832 | $20,338,588 | |
| 2 | NKTR |
Nektar Therapeutics
|
179,247 | $12,896,821 | |
| 3 | CAPR |
Capricor Therapeutics, Inc.
|
178,383 | $5,422,843 | |
| 4 | ABUS |
Arbutus Biopharma Corp
|
514,513 | $2,315,308 | |
| 5 | REPL |
Replimune Group, Inc.
|
287,795 | $2,201,631 | |
| 6 | ABVX |
Abivax S.A.
|
16,000 | $1,781,600 | |
| 7 | SPRB |
Spruce Biosciences, Inc.
|
26,810 | $1,752,033 | |
| 8 | SPRY |
ARS Pharmaceuticals, Inc.
|
155,000 | $1,244,650 |
All Filings in BNTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,338,588 | 228,832 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,378,800 | 56,500 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,268,260 | 23,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,669,735 | 25,075 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $18,024,962 | 197,946 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $40,588,306 | 356,194 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $48,042,465 | 404,500 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $54,908,943 | 683,287 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $65,809,581 | 713,383 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $4,151,250 | 45,000 | Call | Sole | 2024-05-15 | |
| 2023-12-31 | $71,195,489 | 674,583 | Shares | Sole | 2024-02-13 | |
| 2023-12-31 | $4,749,300 | 45,000 | Call | Sole | 2024-02-13 | |
| 2023-09-30 | $71,635,369 | 659,383 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $4,888,800 | 45,000 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $4,856,850 | 45,000 | Call | Sole | 2023-08-11 | |
| 2023-06-30 | $44,209,746 | 409,615 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $43,346,000 | 347,965 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $39,368,305 | 262,071 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $36,425,288 | 270,057 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $44,837,501 | 300,721 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $68,605,883 | 402,239 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $14,743,582 | 57,190 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $545,980 | 2,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,044,760 | 27,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $8,567,047 | 78,460 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $774,440 | 9,500 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||